FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Original Application (MAIA PHARMACEUTICALS)

View source ↗

Summary

The FDA approved Maia Pharmaceuticals' original application for sodium phenylacetate and sodium benzoate, a therapy for managing hyperammonemia in individuals w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Urea Cycle Disorder

Drugs mentioned

• Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

ORIG AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)